Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proline hydroxylase is a family of enzymes that catalyze the hydroxylation of proline residues in proteins, primarily collagen and hypoxia-inducible factor (HIF) alpha subunits. This modification is critical for collagen stability and cellular oxygen sensing. Specifically, prolyl hydroxylase domain proteins (PHDs or EGLNs) regulate cellular responses to oxygen levels by modifying HIF-alpha transcription factors. Inhibition of PHDs stabilizes HIF-alpha, mimicking hypoxic conditions and promoting erythropoiesis and angiogenesis.
Inhibition of proline hydroxylation, leading to HIF stabilization and activation of hypoxic response genes.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline Hydroxylase (PHD).